Movement Alert｜WuXi XDC Falls 4.05% in Regular Trading, Buyback Efforts Fail to Halt Selling Pressure as Stock Trades Over 21% Below Repurchase Price

Market Focus

Jun 11

On June 11, WuXi XDC fell 4.05% in regular trading, trading at 44.92 HKD/share, with trading volume of 18.334 million HKD. The stock has now declined more than 21% below its previous buyback average price of 57.3 HKD, with weakness deepening over consecutive trading sessions.

On the news front, the company previously disclosed that a professional trustee repurchased 5.702 million shares at an average price of 57.3 HKD, totaling approximately 327 million HKD. Parent company WuXi Biologics also announced a buyback plan of up to 400 million USD, bringing the combined WuXi group repurchase scale to 500 million USD. Despite the intensive buyback campaign, selling pressure has not been effectively reversed, with market sentiment remaining subdued.

Within the Life Sciences Tools and Services sector, performance diverged today. WuXi AppTec rose 0.25%, WuXi Biologics fell 1.35%, GenScript Biotech rose 2.41%, XtalPi fell 3.16%, and Insilico fell 3.62%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1110592187"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110592187\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110592187?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-11 09:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110592187","market":"hk","top_or_hot":-1,"title":"Movement Alert｜WuXi XDC Falls 4.05% in Regular Trading, Buyback Efforts Fail to Halt Selling Pressure as Stock Trades Over 21% Below Repurchase Price","media":"Market Focus","content":"<p><p>On June 11, WuXi XDC fell 4.05% in regular trading, trading at 44.92 HKD/share, with trading volume of 18.334 million HKD. The stock has now declined more than 21% below its previous buyback average price of 57.3 HKD, with weakness deepening over consecutive trading sessions.</p><p>On the news front, the company previously disclosed that a professional trustee repurchased 5.702 million shares at an average price of 57.3 HKD, totaling approximately 327 million HKD. Parent company WuXi Biologics also announced a buyback plan of up to 400 million USD, bringing the combined WuXi group repurchase scale to 500 million USD. Despite the intensive buyback campaign, selling pressure has not been effectively reversed, with market sentiment remaining subdued.</p><p>Within the Life Sciences Tools and Services sector, performance diverged today. WuXi AppTec rose 0.25%, WuXi Biologics fell 1.35%, GenScript Biotech rose 2.41%, XtalPi fell 3.16%, and Insilico fell 3.62%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi XDC Falls 4.05% in Regular Trading, Buyback Efforts Fail to Halt Selling Pressure as Stock Trades Over 21% Below Repurchase Price</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi XDC Falls 4.05% in Regular Trading, Buyback Efforts Fail to Halt Selling Pressure as Stock Trades Over 21% Below Repurchase Price\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-11 09:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 11, WuXi XDC fell 4.05% in regular trading, trading at 44.92 HKD/share, with trading volume of 18.334 million HKD. The stock has now declined more than 21% below its previous buyback average price of 57.3 HKD, with weakness deepening over consecutive trading sessions.</p><p>On the news front, the company previously disclosed that a professional trustee repurchased 5.702 million shares at an average price of 57.3 HKD, totaling approximately 327 million HKD. Parent company WuXi Biologics also announced a buyback plan of up to 400 million USD, bringing the combined WuXi group repurchase scale to 500 million USD. Despite the intensive buyback campaign, selling pressure has not been effectively reversed, with market sentiment remaining subdued.</p><p>Within the Life Sciences Tools and Services sector, performance diverged today. WuXi AppTec rose 0.25%, WuXi Biologics fell 1.35%, GenScript Biotech rose 2.41%, XtalPi fell 3.16%, and Insilico fell 3.62%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1110592187","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110592187","pubTimestamp":1781141808,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 11, WuXi XDC fell 4.05% in regular trading, trading at 44.92 HKD/share, with trading volume of 18.334 million HKD. The stock has now declined more than 21% below its previous buyback average...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"走势警报|无锡XDC常规交易下跌4.05%，回购努力未能阻止抛售压力，股价较回购价低21%以上","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On June 11, WuXi XDC fell 4.05% in regular trading, trading at 44.92 HKD/share, with trading volume of 18.334 million HKD. The stock has now declined more than 21% below its previous buyback average price of 57.3 HKD, with weakness deepening over consecutive trading sessions.On the news front, the company previously disclosed that a professional trustee repurchased 5.702 million shares at an average price of 57.3 HKD, totaling approximately 327 million HKD. Parent company WuXi Biologics also announced a buyback plan of up to 400 million USD, bringing the combined WuXi group repurchase scale to 500 million USD. Despite the intensive buyback campaign, selling pressure has not been effectively reversed, with market sentiment remaining subdued.Within the Life Sciences Tools and Services sector, performance diverged today. WuXi AppTec rose 0.25%, WuXi Biologics fell 1.35%, GenScript Biotech rose 2.41%, XtalPi fell 3.16%, and Insilico fell 3.62%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}